comparemela.com

Latest Breaking News On - Rampart pharma - Page 1 : comparemela.com

South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports

South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Americans
Josh-blacher
Michael-rubenstein
Hernan-bazan
Rampart-pharma-inc
Lifesci-communications
Pain-relief-mechanism
Rampart-pharma
Scientific-reports
South-rampart
John-ochsner-endowed-professor

New drug offers safer, non-toxic alternative for pain relief

Details of a unique non-opioid pain relief mechanism called SRP-001 were announced today (May 16) in a paper in Scientific Reports.

Hernan-bazan
Rampart-pharma-inc
South-rampart-pharma
Rampart-pharma

South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials

South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Florida
United-states
Miami
Josh-blacher
Hernan-bazan
Health-national-survey-on-drug
Linkedin
Mental-health-indicators
Mental-health-services-administration
Prnewswire-south-rampart-pharma-inc
National-survey-on-drug
Rampart-pharma-inc

South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain

/PRNewswire/ South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company focused on developing innovative pain.

United-states
Canada
Brazil
Russia
Japan
Mexico
India
China
Australia
Hong-kong
Josh-blacher
Hernan-bazan

vimarsana © 2020. All Rights Reserved.